Phase 1/2 biotech developing novel small molecule therapies for various cancers.
Industry: Health Care
First Day Return: +28.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/06/2020 |
Offer Price | $18.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 9.2 |
Deal Size ($mm) | $165 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/02/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $165 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2014 |
Employees at IPO | 62 |
Website www.zentalis.com |